a public good project by the
Synthesis
Company
of California

© 2026

Daniele Generali | doi.page

0 works0 citations0 h-index

Daniele Generali

University of Trieste(IT)Istituti Ospitalieri di Cremona(IT)

Publications by Year

Research Areas

Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Estrogen and related hormone effects

Most-Cited Works

→ Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data(2014)832 cited
→ Broad targeting of angiogenesis for cancer prevention and therapy(2015)454 cited
→ Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study(2012)366 cited
→ Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function(2005)348 cited
→ Designing a broad-spectrum integrative approach for cancer prevention and treatment(2015)295 cited
→ The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib(2009)292 cited

→ Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis(2018)

279 cited

→ Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact(2011)276 cited

→ The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper(2018)264 cited

→ Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer(2006)242 cited